New Delhi, May 13 (PTI) Suven Life Sciences Ltd on Tuesday reported a widening of consolidated net loss to Rs 43.95 crore in the fourth quarter ended March 31, 2025, hit by a dip in revenue and higher expenses.
The company had posted a consolidated net loss of Rs 26.54 crore in the same quarter previous fiscal, Suven Life Sciences said in a regulatory filing.
Consolidated revenue from operations in the quarter under review stood at Rs 1.47 crore against Rs 2.39 crore in the year-ago period, it added.
Total expenses in the March quarter were higher at Rs 46.63 crore as compared to Rs 34.21 crore in the same period a year ago, the company said.
In the fiscal 2024-25, consolidated net loss widened to Rs 160.75 crore from Rs 105.08 crore in the previous fiscal, it said.
Consolidated revenue from operations in FY25 stood at Rs 6.66 crore as compared to Rs 11.69 crore in FY24, the company said.
Suven Life Sciences Q4 loss widens to Rs 43.95 cr
PTI
Updated: May 13, 2025 14:15 IST
(This story has not been edited by THE WEEK and is auto-generated from PTI)
